Redistribution of Fat and Metabolic Change in HIV Infection: Protocol 2 (FRAM Fat 2)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00244803|
Recruitment Status : Completed
First Posted : October 27, 2005
Last Update Posted : August 31, 2016
|Condition or disease|
|Human Immunodeficiency Virus|
This research is being done to learn whether HIV-infected patients have abnormalities in their blood vessels that could eventually lead to heart attack or stroke (atherosclerosis), in how fat is distributed in their body and in how their body handles fat and sugars. If there are abnormalities, this study will also try to find out what factors may contribute to those abnormalitites.
People who participated in FRAM 1 may join FRAM 2.
|Study Type :||Observational|
|Actual Enrollment :||101 participants|
|Official Title:||Redistribution and Metabolic Change in HIV Infection: Protocol 2 (FRAM Fat 2)|
|Study Start Date :||January 2005|
|Actual Primary Completion Date :||May 2007|
|Actual Study Completion Date :||May 2007|
|HIV Positive FRAM 1 Participant|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00244803
|United States, Maryland|
|Johns Hopkins University, The Clinical Trials Unit|
|Baltimore, Maryland, United States, 21205|
|Principal Investigator:||Joseph Cofrancesco Jr., M.D.||Johns Hopkins University|